In Brief: Pasteur Merieux Connaught DTaP/Hib vaccine
Pasteur Merieux Connaught DTaP/Hib vaccine: Vaccines & Related Biological Products Advisory Committee will review company's PLA for combination Haemophilus b conjugate reconstituted with diphtheria/tetanus/acellular pertussis vaccine for infant immunization on June 5. Clinical trial data required to show prevention of pertussis in adults will also be discussed on June 5. The committee will meet in closed session June 6. The meeting begins at 8 a.m. at the Holiday Inn-Bethesda, Md...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth